UPDATE 1-Array Bio ends late-stage study of ovarian cancer drug
April 01, 2016 at 09:41 AM EDT
April 1 (Reuters) - Array BioPharma Inc said it was abandoning a late-stage study testing its experimental ovarian cancer drug, after an interim analysis showed the trial would likely fail.
